PMCID string | Sentences string | ner list |
|---|---|---|
PMC9429973 | Additionally, hnRNP K overexpressing cells showed NS hallmarks associated with an increase of the number of nucleoli, and total area of the nucleoli and nucleus (Figure 1F-G). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Additionally",
",",
"hnRNP",
"K",
"overexpressing",
"cells",
"showed",
"NS",
"hallmarks",
"associated",
"with",
"an",
"increase",
"of",
"the",
"number",
"of",
"nucleoli",
",",
"and",
"total",
"area",
"of",
"the",
"nucleoli",
"and",
"nucleus",
"(",
"Figure",
"1F-G",
")",
"."
]
}
] |
PMC11190238 | The cohesin complex consists of SMC1, SMC3, RAD21 and SA1 or SA2 proteins. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"cohesin",
"complex",
"consists",
"of",
"SMC1",
",",
"SMC3",
",",
"RAD21",
"and",
"SA1",
"or",
"SA2",
"proteins",
"."
]
}
] |
PMC11098378 | Although it is unknown if SHOC2 restricts S. flexneri infection, this bacterium lacks flagella. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Although",
"it",
"is",
"unknown",
"if",
"SHOC2",
"restricts",
"S.",
"flexneri",
"infection",
",",
"this",
"bacterium",
"lacks",
"flagella",
"."
]
}
] |
PMC9429973 | Genomic imbalances, and in particular deletions, are the most frequent cytogenetic rearrangements in T-ALL. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Genomic",
"imbalances",
",",
"and",
"in",
"particular",
"deletions",
",",
"are",
"the",
"most",
"frequent",
"cytogenetic",
"rearrangements",
"in",
"T-ALL",
"."
]
}
] |
PMC11286266 | As trafficking is closely linked to proteolytic processing, WT ATF6α does not accumulate in the Golgi of stressed cells (Shen et al., 2002). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"As",
"trafficking",
"is",
"closely",
"linked",
"to",
"proteolytic",
"processing",
",",
"WT",
"ATF6α",
"does",
"not",
"accumulate",
"in",
"the",
"Golgi",
"of",
"stressed",
"cells",
"(",
"Shen",
"et",
"al.",
",",
"2002",
")",
"."
]
}
] |
PMC9429973 | Regulatory T cells (TRegs) and T helper 17 cells (Th17) are CD4 T cell functional subsets and their balance (TH17/TReg) is essential for maintaining immune haemostasis Aims: To study T cell subsets and cytokines plasma levels in low risk MDS patients and healthy controls. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Regulatory",
"T",
"cells",
"(",
"TRegs",
")",
"and",
"T",
"helper",
"17",
"cells",
"(",
"Th17",
")",
"are",
"CD4",
"T",
"cell",
"functional",
"subsets",
"and",
"their",
"balance",
"(",
"TH17/TReg",
")",
"is",
"essential",
"for",
"maintaining",
"immune",
"haemostasis",
"Aims",
":",
"To",
"study",
"T",
"cell",
"subsets",
"and",
"cytokines",
"plasma",
"levels",
"in",
"low",
"risk",
"MDS",
"patients",
"and",
"healthy",
"controls",
"."
]
}
] |
PMC11718031 | However, it should be noted cysteine is known to degrade quickly, which may interfere with the quantification of this amino acid (Calvet and Ryder 2014). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"However",
",",
"it",
"should",
"be",
"noted",
"cysteine",
"is",
"known",
"to",
"degrade",
"quickly",
",",
"which",
"may",
"interfere",
"with",
"the",
"quantification",
"of",
"this",
"amino",
"acid",
"(",
"Calvet",
"and",
"Ryder",
"2014",
")",
"."
]
}
] |
PMC9844987 | Weighted average cross correlations were calculated either across all promoters (A-B) or separately for promoter groups split based on their minimum correlation between contained decomposed promoter pairs (high Pearson’s correlation >0.39: top panel, low Pearson’s correlation <= 0.39: bottom panel) (C-D). ( | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Weighted",
"average",
"cross",
"correlations",
"were",
"calculated",
"either",
"across",
"all",
"promoters",
"(",
"A-B",
")",
"or",
"separately",
"for",
"promoter",
"groups",
"split",
"based",
"on",
"their",
"minimum",
"correlation",
"between",
"contained",
"decomposed",
"promoter",
"pairs",
"(",
"high",
"Pearson",
"’s",
"correlation",
">",
"0.39",
":",
"top",
"panel",
",",
"low",
"Pearson",
"’s",
"correlation",
"<",
"=",
"0.39",
":",
"bottom",
"panel",
")",
"(",
"C-D",
")",
".",
"("
]
}
] |
PMC11659734 | Scheme of the comet assay procedure. ( | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Scheme",
"of",
"the",
"comet",
"assay",
"procedure",
".",
"("
]
}
] |
PMC11585587 | As one of the most studied regulatory cascades, the MAPK pathway regulates the direction of cell growth growth. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"As",
"one",
"of",
"the",
"most",
"studied",
"regulatory",
"cascades",
",",
"the",
"MAPK",
"pathway",
"regulates",
"the",
"direction",
"of",
"cell",
"growth",
"growth",
"."
]
}
] |
PMC7039683 | Figure 5—figure supplement 3.Motifs enriched in hOEAEs and shared among zGPAEs, mPEAEs and hOEAEs.(A) Motifs enriched in hOEAEs. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Figure",
"5—figure",
"supplement",
"3.Motifs",
"enriched",
"in",
"hOEAEs",
"and",
"shared",
"among",
"zGPAEs",
",",
"mPEAEs",
"and",
"hOEAEs.(A",
")",
"Motifs",
"enriched",
"in",
"hOEAEs",
"."
]
}
] |
PMC11577421 | These findings underscore the importance of albumin-glycocalyx interactions in the rational design and optimization of albumin-based drug delivery systems. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"These",
"findings",
"underscore",
"the",
"importance",
"of",
"albumin-glycocalyx",
"interactions",
"in",
"the",
"rational",
"design",
"and",
"optimization",
"of",
"albumin-based",
"drug",
"delivery",
"systems",
"."
]
}
] |
PMC11218145 | This response is usually elicited by inducing cell differentiation, apoptosis, and growth arrest. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"This",
"response",
"is",
"usually",
"elicited",
"by",
"inducing",
"cell",
"differentiation",
",",
"apoptosis",
",",
"and",
"growth",
"arrest",
"."
]
}
] |
PMC7723249 | In addition, we found that cytokines/pro-inflammatory factors or other viral factors secreted from CCHFV infected moDC cells enhance the entry of CCHFV contrary to HAZV. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"addition",
",",
"we",
"found",
"that",
"cytokines/pro-inflammatory",
"factors",
"or",
"other",
"viral",
"factors",
"secreted",
"from",
"CCHFV",
"infected",
"moDC",
"cells",
"enhance",
"the",
"entry",
"of",
"CCHFV",
"contrary",
"to",
"HAZV",
"."
]
}
] |
PMC8973085 | calcd for C24H19FN4O3S: C, 62.33; H, 4.14; N, 12.11. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"calcd",
"for",
"C24H19FN4O3S",
":",
"C",
",",
"62.33",
";",
"H",
",",
"4.14",
";",
"N",
",",
"12.11",
"."
]
}
] |
PMC11281366 | The level of background virus capture was subtracted from each data point. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"level",
"of",
"background",
"virus",
"capture",
"was",
"subtracted",
"from",
"each",
"data",
"point",
"."
]
}
] |
PMC11634794 | It is plausible that LAMP1 may be associated with tumor autophagy and VHL gene regulation; nevertheless, its specific mode of action in ccRCC remains elusive. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"It",
"is",
"plausible",
"that",
"LAMP1",
"may",
"be",
"associated",
"with",
"tumor",
"autophagy",
"and",
"VHL",
"gene",
"regulation",
";",
"nevertheless",
",",
"its",
"specific",
"mode",
"of",
"action",
"in",
"ccRCC",
"remains",
"elusive",
"."
]
}
] |
PMC11640247 | Besides the involvement of RAC1, RAC3, and CDC42 variants in multiple NDDs , the Simons Foundation Autism Research Initiative (SFARI) database has identified several GAPs, GEFs, and downstream effectors as candidate genes for autism spectrum disorders (ASDs) . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Besides",
"the",
"involvement",
"of",
"RAC1",
",",
"RAC3",
",",
"and",
"CDC42",
"variants",
"in",
"multiple",
"NDDs",
",",
"the",
"Simons",
"Foundation",
"Autism",
"Research",
"Initiative",
"(",
"SFARI",
")",
"database",
"has",
"identified",
"several",
"GAPs",
",",
"GEFs",
",",
"and",
"downstream",
"effectors",
"as",
"candidate",
"genes",
"for",
"autism",
"spectrum",
"disorders",
"(",
"ASDs",
")",
"."
]
}
] |
PMC9368503 | The development of matched PDX-derived cell lines is non-trivial due to the relatively high failure rate associated with establishing cell lines from tumour specimens and there are only a few reported studies demonstrating success using this approach, including in breast, colorectal, and pancreatic cancers . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"development",
"of",
"matched",
"PDX-derived",
"cell",
"lines",
"is",
"non-trivial",
"due",
"to",
"the",
"relatively",
"high",
"failure",
"rate",
"associated",
"with",
"establishing",
"cell",
"lines",
"from",
"tumour",
"specimens",
"and",
"there",
"are",
"only",
"a",
"few",
"reported",
"studies",
"demonstrating",
"success",
"using",
"this",
"approach",
",",
"including",
"in",
"breast",
",",
"colorectal",
",",
"and",
"pancreatic",
"cancers",
"."
]
}
] |
PMC11752740 | In the cancer group treated with combination therapy for 48 h, Caspase3 gene expression increased approximately 2.4-fold compared to the control group. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"the",
"cancer",
"group",
"treated",
"with",
"combination",
"therapy",
"for",
"48",
"h",
",",
"Caspase3",
"gene",
"expression",
"increased",
"approximately",
"2.4-fold",
"compared",
"to",
"the",
"control",
"group",
"."
]
}
] |
PMC11320834 | Liposomes were extruded gradually using polycarbonate membranes with pore sizes of 200 nm (5 times) and 100 nm (6 times) at room temperature using an extruder device from Northern Lipids Inc. (Vancouver, BC, Canada). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Liposomes",
"were",
"extruded",
"gradually",
"using",
"polycarbonate",
"membranes",
"with",
"pore",
"sizes",
"of",
"200",
"nm",
"(",
"5",
"times",
")",
"and",
"100",
"nm",
"(",
"6",
"times",
")",
"at",
"room",
"temperature",
"using",
"an",
"extruder",
"device",
"from",
"Northern",
"Lipids",
"Inc.",
"(",
"Vancouver",
",",
"BC",
",",
"Canada",
")",
"."
]
}
] |
PMC11530949 | XRD analysis confirmed the crystal structure of the NPs. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"XRD",
"analysis",
"confirmed",
"the",
"crystal",
"structure",
"of",
"the",
"NPs",
"."
]
}
] |
PMC9856122 | A newly established cell-culture model GX-P2V (pangolin coronavirus) such as SARS-CoV-2 model is being used to identify therapeutic drugs against COVID-19. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"A",
"newly",
"established",
"cell-culture",
"model",
"GX-P2V",
"(",
"pangolin",
"coronavirus",
")",
"such",
"as",
"SARS-CoV-2",
"model",
"is",
"being",
"used",
"to",
"identify",
"therapeutic",
"drugs",
"against",
"COVID-19",
"."
]
}
] |
PMC8358176 | In the end, using a microplate reader, the intensity of the dissolved formazan crystals was measured at 540 nm ( 23 - 25 ). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"the",
"end",
",",
"using",
"a",
"microplate",
"reader",
",",
"the",
"intensity",
"of",
"the",
"dissolved",
"formazan",
"crystals",
"was",
"measured",
"at",
"540",
"nm",
"(",
"23",
"-",
"25",
")",
"."
]
}
] |
PMC9429973 | For CD38 nanobody, no significant differences were observed for the MFI values of samples, independent of daratumumab incubation (p=0,139) (figure 1A). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"For",
"CD38",
"nanobody",
",",
"no",
"significant",
"differences",
"were",
"observed",
"for",
"the",
"MFI",
"values",
"of",
"samples",
",",
"independent",
"of",
"daratumumab",
"incubation",
"(",
"p=0,139",
")",
"(",
"figure",
"1A",
")",
"."
]
}
] |
PMC11806182 | Fig. 5Differential gene expression and co-expression analysis based on tissue miR-330 expression in UCEC tissues. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Fig.",
"5Differential",
"gene",
"expression",
"and",
"co-expression",
"analysis",
"based",
"on",
"tissue",
"miR-330",
"expression",
"in",
"UCEC",
"tissues",
"."
]
}
] |
PMC10669966 | Of note, all WDLPS samples (n = 10) were excluded from the analyses, due to low RNA yield from sequencing. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Of",
"note",
",",
"all",
"WDLPS",
"samples",
"(",
"n",
"=",
"10",
")",
"were",
"excluded",
"from",
"the",
"analyses",
",",
"due",
"to",
"low",
"RNA",
"yield",
"from",
"sequencing",
"."
]
}
] |
PMC11411004 | Cells harvested on day 7 were included in the analysis. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Cells",
"harvested",
"on",
"day",
"7",
"were",
"included",
"in",
"the",
"analysis",
"."
]
}
] |
PMC7709199 | This is illustrated by the case study on IL-12B, which requires an immature glycan for proper folding. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"This",
"is",
"illustrated",
"by",
"the",
"case",
"study",
"on",
"IL-12B",
",",
"which",
"requires",
"an",
"immature",
"glycan",
"for",
"proper",
"folding",
"."
]
}
] |
PMC11371627 | Blood group profile revealed blood group type A, Rhesus D positivity (CcD.Ee) and K-k+ (kk) type. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Blood",
"group",
"profile",
"revealed",
"blood",
"group",
"type",
"A",
",",
"Rhesus",
"D",
"positivity",
"(",
"CcD.Ee",
")",
"and",
"K-k+",
"(",
"kk",
")",
"type",
"."
]
}
] |
PMC9429973 | Moreover, we demonstrated that the concomitant inhibition of hepatic and erythroid Tfr2 in anemia of CKD would represent a therapeutic opportunity to simultaneously increase iron availability and erythroid responsiveness in a balanced manner. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Moreover",
",",
"we",
"demonstrated",
"that",
"the",
"concomitant",
"inhibition",
"of",
"hepatic",
"and",
"erythroid",
"Tfr2",
"in",
"anemia",
"of",
"CKD",
"would",
"represent",
"a",
"therapeutic",
"opportunity",
"to",
"simultaneously",
"increase",
"iron",
"availability",
"and",
"erythroid",
"responsiveness",
"in",
"a",
"balanced",
"manner",
"."
]
}
] |
PMC5874706 | At the end of the process, for each amphiphilic α-cyclodextrin used, a 20-mL stock solution of nanoparticles containing 600 μM THN7 was obtained and then stored before use. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"At",
"the",
"end",
"of",
"the",
"process",
",",
"for",
"each",
"amphiphilic",
"α-cyclodextrin",
"used",
",",
"a",
"20-mL",
"stock",
"solution",
"of",
"nanoparticles",
"containing",
"600",
"μM",
"THN7",
"was",
"obtained",
"and",
"then",
"stored",
"before",
"use",
"."
]
}
] |
PMC9429973 | For mouse model study, Vav1-Cre mice, Asxl1 and Jak2 knockin alleles were used to achieve hematopoietic cell-specific Jak2/Asxl1 (Asxl1-/-Jak2), Jak2 (Jak2), and Asxl1 (Asxl1-/-) mice. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"For",
"mouse",
"model",
"study",
",",
"Vav1-Cre",
"mice",
",",
"Asxl1",
"and",
"Jak2",
"knockin",
"alleles",
"were",
"used",
"to",
"achieve",
"hematopoietic",
"cell-specific",
"Jak2/Asxl1",
"(",
"Asxl1-/-Jak2",
")",
",",
"Jak2",
"(",
"Jak2",
")",
",",
"and",
"Asxl1",
"(",
"Asxl1-/-",
")",
"mice",
"."
]
}
] |
PMC9429973 | At last assessment, 27 (30.0%), 46 (51.1%), and 17 (18.9%) of 90 pts had a T-score indicating normal BMD, osteopenia, and osteoporosis (Table). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"At",
"last",
"assessment",
",",
"27",
"(",
"30.0",
"%",
")",
",",
"46",
"(",
"51.1",
"%",
")",
",",
"and",
"17",
"(",
"18.9",
"%",
")",
"of",
"90",
"pts",
"had",
"a",
"T-score",
"indicating",
"normal",
"BMD",
",",
"osteopenia",
",",
"and",
"osteoporosis",
"(",
"Table",
")",
"."
]
}
] |
PMC9429973 | In a cross trial comparison Obinutzumab showed highest proportion of patients with strong MRD response independent from initial CD20 expression, whereas strong response to Ofatumumab seems to correlate with higher CD20 expression levels. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"a",
"cross",
"trial",
"comparison",
"Obinutzumab",
"showed",
"highest",
"proportion",
"of",
"patients",
"with",
"strong",
"MRD",
"response",
"independent",
"from",
"initial",
"CD20",
"expression",
",",
"whereas",
"strong",
"response",
"to",
"Ofatumumab",
"seems",
"to",
"correlate",
"with",
"higher",
"CD20",
"expression",
"levels",
"."
]
}
] |
PMC11704135 | The antitumor activity of some synthesized pyrimidine compounds (10 and 12) against the breast cancer cell line MCF-7 as compared to cisplatin standard antitumor as detected using MTT assay. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"I-CellLine",
"I-CellLine",
"I-CellLine",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"antitumor",
"activity",
"of",
"some",
"synthesized",
"pyrimidine",
"compounds",
"(",
"10",
"and",
"12",
")",
"against",
"the",
"breast",
"cancer",
"cell",
"line",
"MCF-7",
"as",
"compared",
"to",
"cisplatin",
"standard",
"antitumor",
"as",
"detected",
"using",
"MTT",
"assay",
"."
]
}
] |
PMC10490530 | Animal care and euthanasia were performed per the guidelines and approval of the Institutional Animal Ethics Committee (IAEC) recommendations. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Animal",
"care",
"and",
"euthanasia",
"were",
"performed",
"per",
"the",
"guidelines",
"and",
"approval",
"of",
"the",
"Institutional",
"Animal",
"Ethics",
"Committee",
"(",
"IAEC",
")",
"recommendations",
"."
]
}
] |
PMC9429973 | The kinetics and function of CAR-T cells was monitored by quantitative PCR and flow cytometry. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"kinetics",
"and",
"function",
"of",
"CAR-T",
"cells",
"was",
"monitored",
"by",
"quantitative",
"PCR",
"and",
"flow",
"cytometry",
"."
]
}
] |
PMC9429973 | Median (range) age was 63 (44–82) years, 57% were male, and 95% had ≥4 prior MM regimens (median 6 prior MM regimens). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Median",
"(",
"range",
")",
"age",
"was",
"63",
"(",
"44–82",
")",
"years",
",",
"57",
"%",
"were",
"male",
",",
"and",
"95",
"%",
"had",
"≥4",
"prior",
"MM",
"regimens",
"(",
"median",
"6",
"prior",
"MM",
"regimens",
")",
"."
]
}
] |
PMC10850553 | The expression of tissue-type Plasminogen Activator (tPA) and Plasminogen in intracranial aneurysm (IA) lesions. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"expression",
"of",
"tissue-type",
"Plasminogen",
"Activator",
"(",
"tPA",
")",
"and",
"Plasminogen",
"in",
"intracranial",
"aneurysm",
"(",
"IA",
")",
"lesions",
"."
]
}
] |
PMC11055323 | ns, not significant. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"ns",
",",
"not",
"significant",
"."
]
}
] |
PMC11658074 | We employed PBA analysis, which sorts EVs into subpopulations on the basis of their surface proteins . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"employed",
"PBA",
"analysis",
",",
"which",
"sorts",
"EVs",
"into",
"subpopulations",
"on",
"the",
"basis",
"of",
"their",
"surface",
"proteins",
"."
]
}
] |
PMC11604768 | DNA removal from RNA fractions was confirmed by RT-PCR using the SuperScript IV One-Step RT-PCR System (Invitrogen) with and without addition of SuperScript IV RT Mix, followed by agarose gel electrophoresis. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"DNA",
"removal",
"from",
"RNA",
"fractions",
"was",
"confirmed",
"by",
"RT-PCR",
"using",
"the",
"SuperScript",
"IV",
"One-Step",
"RT-PCR",
"System",
"(",
"Invitrogen",
")",
"with",
"and",
"without",
"addition",
"of",
"SuperScript",
"IV",
"RT",
"Mix",
",",
"followed",
"by",
"agarose",
"gel",
"electrophoresis",
"."
]
}
] |
PMC11732628 | Jeon et al. showed that targeting CDCA8 inhibits hepatocellular carcinoma via the restoration of the ATF tumor suppressor (36). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Jeon",
"et",
"al.",
"showed",
"that",
"targeting",
"CDCA8",
"inhibits",
"hepatocellular",
"carcinoma",
"via",
"the",
"restoration",
"of",
"the",
"ATF",
"tumor",
"suppressor",
"(",
"36",
")",
"."
]
}
] |
PMC9444294 | Attempts to detect the protein used in vitro assays have faced challenges. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Attempts",
"to",
"detect",
"the",
"protein",
"used",
"in",
"vitro",
"assays",
"have",
"faced",
"challenges",
"."
]
}
] |
PMC11578343 | More fascinating, mz‐visco‐NPS could enable studies that explore the contributions of different intermediate filaments (IFs) to the viscoelastic properties of cells. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"More",
"fascinating",
",",
"mz‐visco‐NPS",
"could",
"enable",
"studies",
"that",
"explore",
"the",
"contributions",
"of",
"different",
"intermediate",
"filaments",
"(",
"IFs",
")",
"to",
"the",
"viscoelastic",
"properties",
"of",
"cells",
"."
]
}
] |
PMC9577200 | while the expression of caspase-9 was reduced (p < 0.05). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"while",
"the",
"expression",
"of",
"caspase-9",
"was",
"reduced",
"(",
"p",
"<",
"0.05",
")",
"."
]
}
] |
PMC11674891 | We validated CRABP2 and FNDC4 levels in A427 cells overexpressing GRPR. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"validated",
"CRABP2",
"and",
"FNDC4",
"levels",
"in",
"A427",
"cells",
"overexpressing",
"GRPR",
"."
]
}
] |
PMC8427838 | Moesin was one of the distinct proteins identified in these GST-TMIGD1 pull-downs (Fig. 1B). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Moesin",
"was",
"one",
"of",
"the",
"distinct",
"proteins",
"identified",
"in",
"these",
"GST-TMIGD1",
"pull-downs",
"(",
"Fig.",
"1B",
")",
"."
]
}
] |
PMC11755519 | The level of DNA damage was then assessed by measuring histone H2AX phosphorylation. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"level",
"of",
"DNA",
"damage",
"was",
"then",
"assessed",
"by",
"measuring",
"histone",
"H2AX",
"phosphorylation",
"."
]
}
] |
PMC11747467 | We further analyzed basal and luminal types determined by other classification systems ( Supplementary Figure S9A ). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"further",
"analyzed",
"basal",
"and",
"luminal",
"types",
"determined",
"by",
"other",
"classification",
"systems",
"(",
"Supplementary",
"Figure",
"S9A",
")",
"."
]
}
] |
PMC8316344 | We speculate that TFRC is degraded via PSMB5 but not PSMB1 and PSMB2 following ubiquitination, because PSMB5 is stimulated once upon TRIB2 is upregulated ; however, the exact mechanism underlying how TFRC is degraded in the proteasome will be discussed in the future. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"speculate",
"that",
"TFRC",
"is",
"degraded",
"via",
"PSMB5",
"but",
"not",
"PSMB1",
"and",
"PSMB2",
"following",
"ubiquitination",
",",
"because",
"PSMB5",
"is",
"stimulated",
"once",
"upon",
"TRIB2",
"is",
"upregulated",
";",
"however",
",",
"the",
"exact",
"mechanism",
"underlying",
"how",
"TFRC",
"is",
"degraded",
"in",
"the",
"proteasome",
"will",
"be",
"discussed",
"in",
"the",
"future",
"."
]
}
] |
PMC11806106 | We further performed BRET-based assays to measure the G protein activation induced by MOR agonists. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"further",
"performed",
"BRET-based",
"assays",
"to",
"measure",
"the",
"G",
"protein",
"activation",
"induced",
"by",
"MOR",
"agonists",
"."
]
}
] |
PMC10006224 | These and additional antibodies used in this study are listed in Supplementary Table 7. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"These",
"and",
"additional",
"antibodies",
"used",
"in",
"this",
"study",
"are",
"listed",
"in",
"Supplementary",
"Table",
"7",
"."
]
}
] |
PMC10854447 | VEGFR-2, a VEGFR family member, is a major mediator in tumour angiogenesis and is essential for solid tumour formation. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"VEGFR-2",
",",
"a",
"VEGFR",
"family",
"member",
",",
"is",
"a",
"major",
"mediator",
"in",
"tumour",
"angiogenesis",
"and",
"is",
"essential",
"for",
"solid",
"tumour",
"formation",
"."
]
}
] |
PMC5261804 | Ten of the top 20 PPIs involved CTNNB1, while 8 of 20 involved AKT1. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Ten",
"of",
"the",
"top",
"20",
"PPIs",
"involved",
"CTNNB1",
",",
"while",
"8",
"of",
"20",
"involved",
"AKT1",
"."
]
}
] |
PMC5716223 | b Trypan blue exclusion assay. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"b",
"Trypan",
"blue",
"exclusion",
"assay",
"."
]
}
] |
PMC11185260 | Representative photographs of senescence-associated β-galactosidase staining of BT-12 and A-204. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"B-CellLine",
"O"
],
"tokens": [
"Representative",
"photographs",
"of",
"senescence-associated",
"β-galactosidase",
"staining",
"of",
"BT-12",
"and",
"A-204",
"."
]
}
] |
PMC9370419 | Sex hormones have been reported to be associated with HBV infection and the risk of HCC. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Sex",
"hormones",
"have",
"been",
"reported",
"to",
"be",
"associated",
"with",
"HBV",
"infection",
"and",
"the",
"risk",
"of",
"HCC",
"."
]
}
] |
PMC11502066 | CB1R, a GPCR activated by cannabinoids, is mostly expressed in several brain regions but also in some peripheral areas such as gastrointestinal tract and smooth muscles, where it performs a number of activities . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"CB1R",
",",
"a",
"GPCR",
"activated",
"by",
"cannabinoids",
",",
"is",
"mostly",
"expressed",
"in",
"several",
"brain",
"regions",
"but",
"also",
"in",
"some",
"peripheral",
"areas",
"such",
"as",
"gastrointestinal",
"tract",
"and",
"smooth",
"muscles",
",",
"where",
"it",
"performs",
"a",
"number",
"of",
"activities",
"."
]
}
] |
PMC11483468 | The β-galactosidase staining result showed that more than half of the cells became senescent at the sixth week. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"β-galactosidase",
"staining",
"result",
"showed",
"that",
"more",
"than",
"half",
"of",
"the",
"cells",
"became",
"senescent",
"at",
"the",
"sixth",
"week",
"."
]
}
] |
PMC9275501 | NS made from hydrophobic drugs have the advantages of increasing drug loading, improving solubility, improving bioavailability (Sahu et al., 2016), and reducing side effects (Wang et al., 2019d). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"NS",
"made",
"from",
"hydrophobic",
"drugs",
"have",
"the",
"advantages",
"of",
"increasing",
"drug",
"loading",
",",
"improving",
"solubility",
",",
"improving",
"bioavailability",
"(",
"Sahu",
"et",
"al.",
",",
"2016",
")",
",",
"and",
"reducing",
"side",
"effects",
"(",
"Wang",
"et",
"al.",
",",
"2019d",
")",
"."
]
}
] |
PMC10440586 | Pro., | [
{
"tags": [
"O",
"O",
"O"
],
"tokens": [
"Pro",
".",
","
]
}
] |
PMC11489175 | Targeting of USP8 reduces survival pathway activation in ovarian carcinoma preclinical models of cisplatin resistance 90, offering novel opportunities for drug development in this disease and in many neoplastic diseases with a key role for EGFR activation including for example lung cancer in which down-regulation of the HER family receptor phosphorylation was observed following molecular and pharmacological inhibition of USP8 91. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Targeting",
"of",
"USP8",
"reduces",
"survival",
"pathway",
"activation",
"in",
"ovarian",
"carcinoma",
"preclinical",
"models",
"of",
"cisplatin",
"resistance",
"90",
",",
"offering",
"novel",
"opportunities",
"for",
"drug",
"development",
"in",
"this",
"disease",
"and",
"in",
"many",
"neoplastic",
"diseases",
"with",
"a",
"key",
"role",
"for",
"EGFR",
"activation",
"including",
"for",
"example",
"lung",
"cancer",
"in",
"which",
"down-regulation",
"of",
"the",
"HER",
"family",
"receptor",
"phosphorylation",
"was",
"observed",
"following",
"molecular",
"and",
"pharmacological",
"inhibition",
"of",
"USP8",
"91",
"."
]
}
] |
PMC11301095 | Neck stiffness was noted, and superficial lymph nodes were not palpably enlarged. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Neck",
"stiffness",
"was",
"noted",
",",
"and",
"superficial",
"lymph",
"nodes",
"were",
"not",
"palpably",
"enlarged",
"."
]
}
] |
PMC10812665 | It was found that planar polychlorinated biphenyls (PCBs) impaired neural crest function by affecting cellular gap junctions. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"It",
"was",
"found",
"that",
"planar",
"polychlorinated",
"biphenyls",
"(",
"PCBs",
")",
"impaired",
"neural",
"crest",
"function",
"by",
"affecting",
"cellular",
"gap",
"junctions",
"."
]
}
] |
PMC10728535 | However, in some tumors, this gene plays an oncogenic role and induces cell growth and proliferation. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"However",
",",
"in",
"some",
"tumors",
",",
"this",
"gene",
"plays",
"an",
"oncogenic",
"role",
"and",
"induces",
"cell",
"growth",
"and",
"proliferation",
"."
]
}
] |
PMC11753435 | All ipTM scores, targets, and peptide sequences are provided in data file S1. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"All",
"ipTM",
"scores",
",",
"targets",
",",
"and",
"peptide",
"sequences",
"are",
"provided",
"in",
"data",
"file",
"S1",
"."
]
}
] |
PMC9105697 | Target regions were pulled down with streptavidin-coated magnetic beads. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Target",
"regions",
"were",
"pulled",
"down",
"with",
"streptavidin-coated",
"magnetic",
"beads",
"."
]
}
] |
PMC11705067 | The molecular docking results indicated that FDX1 and DLAT might be potential drug targets for mitotane, adicicol and dihydrolipoic acid against ccRCC by inducing cuproptosis. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"molecular",
"docking",
"results",
"indicated",
"that",
"FDX1",
"and",
"DLAT",
"might",
"be",
"potential",
"drug",
"targets",
"for",
"mitotane",
",",
"adicicol",
"and",
"dihydrolipoic",
"acid",
"against",
"ccRCC",
"by",
"inducing",
"cuproptosis",
"."
]
}
] |
PMC11525293 | We first investigated whether Thal or Len could modulate the expression of ACE2 receptor in association with ΔNp63α degradation in human cells, such as HaCaT keratinocytes, A431 epidermoid cells, and A549 lung carcinoma cells, which express both ΔNp63α and ACE2 proteins. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"B-CellLine",
"B-CellLine",
"O",
"O",
"O",
"B-CellLine",
"I-CellLine",
"I-CellLine",
"I-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"We",
"first",
"investigated",
"whether",
"Thal",
"or",
"Len",
"could",
"modulate",
"the",
"expression",
"of",
"ACE2",
"receptor",
"in",
"association",
"with",
"ΔNp63α",
"degradation",
"in",
"human",
"cells",
",",
"such",
"as",
"HaCaT",
"keratinocytes",
",",
"A431",
"epidermoid",
"cells",
",",
"and",
"A549",
"lung",
"carcinoma",
"cells",
",",
"which",
"express",
"both",
"ΔNp63α",
"and",
"ACE2",
"proteins",
"."
]
}
] |
PMC9429973 | The study was approved by the local institutional review board and supported by Sanofi Genzyme. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"study",
"was",
"approved",
"by",
"the",
"local",
"institutional",
"review",
"board",
"and",
"supported",
"by",
"Sanofi",
"Genzyme",
"."
]
}
] |
PMC11401350 | As expected, these trials including only a few PTCL patients might not give a clear-cut outcome and conclusion in terms of therapeutic benefit for these cancer patients. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"As",
"expected",
",",
"these",
"trials",
"including",
"only",
"a",
"few",
"PTCL",
"patients",
"might",
"not",
"give",
"a",
"clear-cut",
"outcome",
"and",
"conclusion",
"in",
"terms",
"of",
"therapeutic",
"benefit",
"for",
"these",
"cancer",
"patients",
"."
]
}
] |
PMC11180402 | E–F) Invasion abilities of 5637 (vector) and 5637 (Myc-DNMT3b) cells with/without ISO evaluated by Transwell assay (E), with relative invasion plotted (F). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"B-CellLine",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"E",
"–",
"F",
")",
"Invasion",
"abilities",
"of",
"5637",
"(",
"vector",
")",
"and",
"5637",
"(",
"Myc-DNMT3b",
")",
"cells",
"with/without",
"ISO",
"evaluated",
"by",
"Transwell",
"assay",
"(",
"E",
")",
",",
"with",
"relative",
"invasion",
"plotted",
"(",
"F",
")",
"."
]
}
] |
PMC7185206 | Advanced melanomas are commonly treated with a PD-1 inhibitor such as pembrolizumab for first-line therapy, although most tumors exhibit or acquire resistance to treatment. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Advanced",
"melanomas",
"are",
"commonly",
"treated",
"with",
"a",
"PD-1",
"inhibitor",
"such",
"as",
"pembrolizumab",
"for",
"first-line",
"therapy",
",",
"although",
"most",
"tumors",
"exhibit",
"or",
"acquire",
"resistance",
"to",
"treatment",
"."
]
}
] |
PMC9429973 | Across the 2 groups there was no difference in RFS or OS between pts who attained early or late OPR. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Across",
"the",
"2",
"groups",
"there",
"was",
"no",
"difference",
"in",
"RFS",
"or",
"OS",
"between",
"pts",
"who",
"attained",
"early",
"or",
"late",
"OPR",
"."
]
}
] |
PMC6222726 | revealed that the most common lignan types are dibenzyl butyrolactones (nine compounds), picro aryltetraline derivatives (three compounds), aryltetraline derivatives (nine compounds), 7′,8′-dehydro-aryltetraline derivatives (five compounds), and dibenzylbutane diols (eight compounds). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"revealed",
"that",
"the",
"most",
"common",
"lignan",
"types",
"are",
"dibenzyl",
"butyrolactones",
"(",
"nine",
"compounds",
")",
",",
"picro",
"aryltetraline",
"derivatives",
"(",
"three",
"compounds",
")",
",",
"aryltetraline",
"derivatives",
"(",
"nine",
"compounds",
")",
",",
"7′,8′-dehydro-aryltetraline",
"derivatives",
"(",
"five",
"compounds",
")",
",",
"and",
"dibenzylbutane",
"diols",
"(",
"eight",
"compounds",
")",
"."
]
}
] |
PMC11487720 | Confocal or immunofluorescence microscopy was then carried out. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Confocal",
"or",
"immunofluorescence",
"microscopy",
"was",
"then",
"carried",
"out",
"."
]
}
] |
PMC11680982 | This therapeutic approach is also used as an adjuvant therapy for early-stage HR/HER2 subtypes in high-risk populations. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"This",
"therapeutic",
"approach",
"is",
"also",
"used",
"as",
"an",
"adjuvant",
"therapy",
"for",
"early-stage",
"HR/HER2",
"subtypes",
"in",
"high-risk",
"populations",
"."
]
}
] |
PMC11078693 | Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Kylie Walters (kylie.walters@nih.gov). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Further",
"information",
"and",
"requests",
"for",
"resources",
"and",
"reagents",
"should",
"be",
"directed",
"to",
"and",
"will",
"be",
"fulfilled",
"by",
"the",
"lead",
"contact",
",",
"Kylie",
"Walters",
"(",
"kylie.walters@nih.gov",
")",
"."
]
}
] |
PMC9429973 | Despite relative high treatment discontinuation rates, adequate RDI levels were achieved and TRM did not exceed that reported for attenuated regimens in previous prospective trials. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Despite",
"relative",
"high",
"treatment",
"discontinuation",
"rates",
",",
"adequate",
"RDI",
"levels",
"were",
"achieved",
"and",
"TRM",
"did",
"not",
"exceed",
"that",
"reported",
"for",
"attenuated",
"regimens",
"in",
"previous",
"prospective",
"trials",
"."
]
}
] |
PMC10713411 | Additionally, with the increasing study of PCD, different types of PCD such as parthanatos , entotic cell death , netotic cell death , lysosome-dependent cell death , alkaliptosis , oxciptosis , anoikis , etc., | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Additionally",
",",
"with",
"the",
"increasing",
"study",
"of",
"PCD",
",",
"different",
"types",
"of",
"PCD",
"such",
"as",
"parthanatos",
",",
"entotic",
"cell",
"death",
",",
"netotic",
"cell",
"death",
",",
"lysosome-dependent",
"cell",
"death",
",",
"alkaliptosis",
",",
"oxciptosis",
",",
"anoikis",
",",
"etc",
".",
","
]
}
] |
PMC11291490 | To overcome the major problem of low immunogenicity of DNA vaccines, effective delivery of plasmids to preferred tissues or cells is a key area of research, including codelivery with nanoparticles and bacterial vectors. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"To",
"overcome",
"the",
"major",
"problem",
"of",
"low",
"immunogenicity",
"of",
"DNA",
"vaccines",
",",
"effective",
"delivery",
"of",
"plasmids",
"to",
"preferred",
"tissues",
"or",
"cells",
"is",
"a",
"key",
"area",
"of",
"research",
",",
"including",
"codelivery",
"with",
"nanoparticles",
"and",
"bacterial",
"vectors",
"."
]
}
] |
PMC11678368 | The theoretical structural analysis of the investigated metal complexes of 4-chloro and 5-chloro derivatives of 7-azaindole-3-carbaldehyde (trans-[PdCl2(4ClL)2] and trans-[MCl2(5ClL)2], where M = Pd(II) or Pt(II)) provides important information about their relative stability. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"theoretical",
"structural",
"analysis",
"of",
"the",
"investigated",
"metal",
"complexes",
"of",
"4-chloro",
"and",
"5-chloro",
"derivatives",
"of",
"7-azaindole-3-carbaldehyde",
"(",
"trans-[PdCl2(4ClL)2",
"]",
"and",
"trans-[MCl2(5ClL)2",
"]",
",",
"where",
"M",
"=",
"Pd(II",
")",
"or",
"Pt(II",
")",
")",
"provides",
"important",
"information",
"about",
"their",
"relative",
"stability",
"."
]
}
] |
PMC11756514 | The percentage of S. aureus-positive cells was determined by flow cytometry. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"percentage",
"of",
"S.",
"aureus-positive",
"cells",
"was",
"determined",
"by",
"flow",
"cytometry",
"."
]
}
] |
PMC9429973 | There is currently a growing tendency to treat as many patients as possible because of the favorable impact of treatment on survival. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"There",
"is",
"currently",
"a",
"growing",
"tendency",
"to",
"treat",
"as",
"many",
"patients",
"as",
"possible",
"because",
"of",
"the",
"favorable",
"impact",
"of",
"treatment",
"on",
"survival",
"."
]
}
] |
PMC7185206 | In figures, p values are denoted <0.05 with *, <0.01 with **, and <0.001 with ***. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"figures",
",",
"p",
"values",
"are",
"denoted",
"<",
"0.05",
"with",
"*",
",",
"<",
"0.01",
"with",
"*",
"*",
",",
"and",
"<",
"0.001",
"with",
"*",
"*",
"*",
"."
]
}
] |
PMC9429973 | In this latter case, it may be the first or even the only symptom. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"In",
"this",
"latter",
"case",
",",
"it",
"may",
"be",
"the",
"first",
"or",
"even",
"the",
"only",
"symptom",
"."
]
}
] |
PMC11190062 | The main finding of this work is that TLR9 and TLR4 activation increases the expression of pro-survival genes, provides resistance to both reversible and irreversible proteasome inhibitors, and, at the same time, reduces the expression of BCMA, a broadly expressed surface protein and a target for bispecific antibody therapy and CAR T cells in MM. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"The",
"main",
"finding",
"of",
"this",
"work",
"is",
"that",
"TLR9",
"and",
"TLR4",
"activation",
"increases",
"the",
"expression",
"of",
"pro-survival",
"genes",
",",
"provides",
"resistance",
"to",
"both",
"reversible",
"and",
"irreversible",
"proteasome",
"inhibitors",
",",
"and",
",",
"at",
"the",
"same",
"time",
",",
"reduces",
"the",
"expression",
"of",
"BCMA",
",",
"a",
"broadly",
"expressed",
"surface",
"protein",
"and",
"a",
"target",
"for",
"bispecific",
"antibody",
"therapy",
"and",
"CAR",
"T",
"cells",
"in",
"MM",
"."
]
}
] |
PMC11098378 | Y2H screening was conducted by Hybrigenics Services (Boston, MA). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Y2H",
"screening",
"was",
"conducted",
"by",
"Hybrigenics",
"Services",
"(",
"Boston",
",",
"MA",
")",
"."
]
}
] |
PMC11469524 | However, there is a substantial crosstalk between these different downstream signaling molecules not yet characterized in sufficient detail. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"However",
",",
"there",
"is",
"a",
"substantial",
"crosstalk",
"between",
"these",
"different",
"downstream",
"signaling",
"molecules",
"not",
"yet",
"characterized",
"in",
"sufficient",
"detail",
"."
]
}
] |
PMC10589262 | Tumor volume was measured using a digital Vernier caliper (Mitutoyo; Kanagawa, Japan) three times a week after implantation and was calculated as 1/2 × length × width . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Tumor",
"volume",
"was",
"measured",
"using",
"a",
"digital",
"Vernier",
"caliper",
"(",
"Mitutoyo",
";",
"Kanagawa",
",",
"Japan",
")",
"three",
"times",
"a",
"week",
"after",
"implantation",
"and",
"was",
"calculated",
"as",
"1/2",
"×",
"length",
"×",
"width",
"."
]
}
] |
PMC11371747 | SEM was within the size of the marker. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"SEM",
"was",
"within",
"the",
"size",
"of",
"the",
"marker",
"."
]
}
] |
PMC11757230 | Histopathologic examination revealed that the tumors formed in the xenografts had a similar histology across all groups (Fig. 5f). | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Histopathologic",
"examination",
"revealed",
"that",
"the",
"tumors",
"formed",
"in",
"the",
"xenografts",
"had",
"a",
"similar",
"histology",
"across",
"all",
"groups",
"(",
"Fig.",
"5f",
")",
"."
]
}
] |
PMC9429973 | Therefore, these markers have the potential to be used to identify individuals at increased risk of developing a destructive syndrome, and in conjunction with other risk factors (IgM secretion of more than 10% of CD 138+ plasma cells on immunohistochemistry) and to identify patients at increased risk of progression during MM. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Therefore",
",",
"these",
"markers",
"have",
"the",
"potential",
"to",
"be",
"used",
"to",
"identify",
"individuals",
"at",
"increased",
"risk",
"of",
"developing",
"a",
"destructive",
"syndrome",
",",
"and",
"in",
"conjunction",
"with",
"other",
"risk",
"factors",
"(",
"IgM",
"secretion",
"of",
"more",
"than",
"10",
"%",
"of",
"CD",
"138",
"+",
"plasma",
"cells",
"on",
"immunohistochemistry",
")",
"and",
"to",
"identify",
"patients",
"at",
"increased",
"risk",
"of",
"progression",
"during",
"MM",
"."
]
}
] |
PMC8357004 | Overexpression of TSGs plays a significant role in the induction and development of many cancers comprising gastric cancer, ovarian cancer, and colorectal cancers. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Overexpression",
"of",
"TSGs",
"plays",
"a",
"significant",
"role",
"in",
"the",
"induction",
"and",
"development",
"of",
"many",
"cancers",
"comprising",
"gastric",
"cancer",
",",
"ovarian",
"cancer",
",",
"and",
"colorectal",
"cancers",
"."
]
}
] |
PMC6684588 | n = 10–12). ( | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"n",
"=",
"10–12",
")",
".",
"("
]
}
] |
PMC11129910 | Our previous work demonstrated that Rab25 significantly suppressed the levels of VEGF-A, VEGFR-1 mRNA, and VEGFR-1 protein. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Our",
"previous",
"work",
"demonstrated",
"that",
"Rab25",
"significantly",
"suppressed",
"the",
"levels",
"of",
"VEGF-A",
",",
"VEGFR-1",
"mRNA",
",",
"and",
"VEGFR-1",
"protein",
"."
]
}
] |
PMC10936243 | Figure 2.Percentage of basic resources available for post-OVH cats as reported by participants. | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"Figure",
"2.Percentage",
"of",
"basic",
"resources",
"available",
"for",
"post-OVH",
"cats",
"as",
"reported",
"by",
"participants",
"."
]
}
] |
PMC11627398 | MTF1 can protect cells under high copper conditions through activating metallothioneins, while it also can obtain scarce copper from the surroundings upon copper starvation through upregulating Ctr1B (a copper importer) . | [
{
"tags": [
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O",
"O"
],
"tokens": [
"MTF1",
"can",
"protect",
"cells",
"under",
"high",
"copper",
"conditions",
"through",
"activating",
"metallothioneins",
",",
"while",
"it",
"also",
"can",
"obtain",
"scarce",
"copper",
"from",
"the",
"surroundings",
"upon",
"copper",
"starvation",
"through",
"upregulating",
"Ctr1B",
"(",
"a",
"copper",
"importer",
")",
"."
]
}
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.